![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
Real world data from a large Nordic study shows that use of liraglutide, a drug for type 2 diabetes, is associated with a lower risk of myocardial infarction, stroke or cardiovascular death.
Cancer patients who take beta-blocker along with breast cancer drug have less heart damage
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a study presented today at EuroEcho-Imaging 2018.
Duurste medicijn kan plotseling 80 procent goedkoper
Het medicijn waar in Nederland het meeste geld aan wordt uitgegeven daalt sterk in prijs. Fabrikant Abbvie van het middel Humira, dat wordt gebruikt tegen reuma en bij darmziektes, verlaagt de prijs van het medicijn met...
Optimization of drug dose sizes can reduce pharmaceutical wastage
Pharmaceuticals are often dosed according to patient weight or body size which means that a dose must be individually measured. In a new study, lead author Anthony Hatswell of Delta Hat Limited and University College...
Common antidepressant does not promote recovery after stroke, study finds
Stroke patients prescribed a common antidepressant show no improvement compared with those given a dummy drug, a study has found.
Advies KNMP bij nieuwe recall: valsartan wederom terug naar de apotheek
5 december 2018 Het bestuur van de KNMP roept de Nederlandse apothekers wederom op patiënten te vragen vervuilde valsartan terug te brengen naar de apotheek. Het betreft deze keer een terugroepactie van de merken Mylan...
Wek de (bijna) dode allround marketeer weer tot leven
Gezocht: SEO-marketeer, SEA-marketeer, e-mailmarketeer, contentmarketeer, databasemarketeer, kanaalmarketeer en zo kan ik nog wel even doorgaan. Het gaat goed met de economie, en dus wordt er weer meer geïnvesteerd in...
Man opgepakt voor illegale handel in geneesmiddelen
Een man uit Bodegraven is opgepakt omdat hij illegaal in medicijnen zou hebben gehandeld. De inspectie heeft duizenden flesjes met groeihormonen, geneesmiddelen en 57.000 dollar aan bitcoins in beslag genomen. Ook is...
Johnson & Johnson’s multiple myeloma drug reduces risk of death in late-stage study
Johnson & Johnson’s blockbuster blood cancer drug Darzalex significantly reduced the risk of disease progression or death in patients who have not been previously treated for multiple myeloma, late-stage study...
Roche’s Tecentriq wins speedy U.S. review in small cell lung cancer
Roche’s Tecentriq immunotherapy with chemotherapy won priority review in the United States for the initial treatment of extensive-stage small cell lung cancer (SCLC), the company said, setting up possible approval...
EMA publishes revised guideline to assess risk of human medicines for environment
The European Medicines Agency (EMA) has published a revision of its guideline on the environmental risk assessment (ERA) of human medicines for a six-month public consultation. Stakeholders are invited to send their...
Shire’s Takhzyro scores EU approval in rare genetic disorder hereditary angioedema
Shire has announced that it has secured European approval for its subcutaneous injection Takhzyro (lanadelumab) for the routine prevention of attacks as a result of hereditary angioedema (HAE), a rare genetic disorder...
Nikki Mendonça (Accenture Interactive): ‘Marketing wordt eindelijk volwassen’
De reclamewereld verandert, mede door de toetreding van consultancy-bedrijven zoals Accenture Interactive. Ze hebben een strategischer blikveld, maar doen ook creatieve overnames. ‘Bedrijven en CMO’s willen marketing...
Despite innovation, Europeans wait years for new cancer drugs
Rapid advances in cancer science have increased the number of new oncology drugs being developed, but delays in regulation and approvals mean patients in Europe often wait years to be able to access them, researchers...
New drug combination could kill melanoma cells more effectively, study shows
A class of cancer drugs called protein kinase inhibitors is one of the most effective treatments for melanoma. However, in many cases, tumors eventually become resistant to the drugs and cause a relapse in the patient...
5 Tips voor meer traffic door content marketing
U wilt graag conversie.. maar zonder bezoekers komt u er niet! Content is tegenwoordig dé manier om uw expertise te tonen. Artikelen blijven waar een advertentie uit beeld verdwijnt. Wij zetten voor u 5 tips op een...
Novartis’ Gilenya scores paediatric EU approval for advanced relapsing-remitting MS
Novartis has announced that Gilenya (fingolimod) has received marketing authorisation from the European Commission for the treatment of relapsing-remitting forms of multiple sclerosis (RRMS) in patients aged between 10...
Boehringer Ingelheim’s NexGard & NexGard Spectra gets approval to treat cutaneous diseases demodicosis and sarcoptic mange in EU & Australia
Boehringer Ingelheim received approval to expand the label claims for its NexGard brands for the treatment of two severe skin diseases in dogs. Both NexGard and NexGard Spectra are now approved for the treatment of the...
